3,5-Diacetoxybenzoic acid

Catalog No. :
ACIWPJ423
CAS No. :
35354-29-1
Molecular Formula :
C11H10O6
Molecular Weight :
238.20

IUPAC Name:3,5-diacetoxybenzoic acid

3,5-Diacetoxybenzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$51.00Login to see priceIn stockInquiry
25g98%$107.00Login to see priceIn stockInquiry
100g98%$293.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-Diacetoxybenzoic acid
IUPAC Name3,5-diacetoxybenzoic acid
MDL No.MFCD00017591
Molecular FormulaC11H10O6
Molecular Weight238.20
SMILESO=C(O)C1=CC(OC(C)=O)=CC(OC(C)=O)=C1
InChI KeyQBTDQJMLMVEUTQ-UHFFFAOYSA-N
SynonymOprea1_191803 | SB36791 | QBTDQJMLMVEUTQ-UHFFFAOYSA- | 3,5-Diacetoxy Benzoic Acid | 3,5-Diacetoxybenzoic acid | 3,5-Diacetoxy-benzoic acid | a-Resorcylic acid, diacetate | SCHEMBL417129 | 3,5-Bis(acetyloxy)benzoic acid # | STK894907 | AKOS005614430 | MFCD
CAS No.35354-29-1
PubChem CID539869

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACIWPJ423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSZVG806 route compound structure diagram
    ACSZVG80699-10-5 In Stock
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACIWPJ423 route product structure diagram
    ACIWPJ42335354-29-1 In Stock
Inquiry

2. ACIWPJ423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWPJ423 route product structure diagram
    ACIWPJ42335354-29-1 In Stock
Inquiry

Comments (0)